4 Cases of Reactivated Cytomegalovirus Retinitis in Immunocompromised Patients
10.52725/aocl.2025.24.1.39
- Author:
Seung Ahn YANG
1
;
Su Hwan PARK
;
Ji Eun LEE
;
Seung Min LEE
Author Information
1. Department of Ophthalmology, Pusan National University Yangsan Hospital, Yangsan, Korea
- Publication Type:Case Report
- From:
Annals of Optometry and Contact Lens
2025;24(1):39-47
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Purpose:This study aimed to report a series of cases of cytomegalovirus retinitis reactivation in immunocompromised patients, focusing on the characteristic clinical and laboratory findings associated with reactivation.Case summary: We retrospectively reviewed the medical records of patients diagnosed with cytomegalovirus retinitis at our clinic between January 2012 and November 2023. We analyzed ophthalmologic clinical findings and diagnostic test results, including quantitative cytomegalovirus polymerase chain reaction (CMV PCR). Reactivation was defined as the resolution or stabilization of the overall lesions on fundus examination, followed by the identification of new retinitis or vitreitis findings. The analysis excluded patients with cytomegalovirus retinitis resistant to ganciclovir or foscarnet. Among 24 patients (34 eyes) treated for cytomegalovirus retinitis, four showed reactivation, and the remaining 20 patients showed improvement with initial treatment. Recurrence occurred at an average of 24.8 days (18–35) after discontinuation of ganciclovir maintenance treatment, and in all cases, new lesions were discovered at the border of existing lesions. The CMV PCR test value tended to increase an average of 8 days (4–14) before recurrence was observed on fundus examination, and declined absolute neutrophil count preceded the increase in CMV PCR by an average of 12.8 days (6–26).
Conclusions:Monitoring quantitative CMV PCR tests in immunocompromised patients with cytomegalovirus retinitis could be helpful in predicting reactivation.
